|
1DTD
CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE LEECH CARBOXYPEPTIDASE INHIBITOR AND THE HUMAN CARBOXYPEPTIDASE A2 (LCI-CPA2)
Deposited 2000-01-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
20–80(61 aa)
|
Not recorded
|
ZN ZINC ION × 1
GLU GLUTAMIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;298 K;ammonium phosphate, sodium citrate, pH 7.5, VAPOR DIFFUSION, temperature 298.0K
|
Resolution 1.65 Å
R-free 0.234
|
|
1ZFI
Solution structure of the leech carboxypeptidase inhibitor
Deposited 2005-04-20
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
16–81(66 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3.5;300 K;Ionic strength (raw mmCIF value) 20mM phosphate buffer;Pressure ambient
NMR sample composition
1mM 15N-labeled leech carboxypeptidase inhibitor; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1mM 15N-labeled leech carboxypeptidase inhibitor; 100% D2O | 100% D2O
|
Resolution not provided
|
|
1ZFL
Solution structure of III-A, the major intermediate in the oxidative folding of leech carboxypeptidase inhibitor
Deposited 2005-04-20
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
16–81(66 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 3.5;300 K;Ionic strength (raw mmCIF value) 20mM phosphate buffer;Pressure ambient
NMR sample composition
1mM 15N-labeled III-A intermediate; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1mM 15N-labeled III-A intermediate; 100% D2O | 100% D2O
|
Resolution not provided
|
|
2ABZ
Crystal structure of C19A/C43A mutant of leech carboxypeptidase inhibitor in complex with bovine carboxypeptidase A
Deposited 2005-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
16–81(66 aa)
Chain D
16–81(66 aa)
Chain E
16–81(66 aa)
Chain F
16–81(66 aa)
|
Mutation:C19A/C43A
Mutation:C19A/C43A
Mutation:C19A/C43A
Mutation:C19A/C43A
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;1.5M Lithium Sulfate monohydrate, 100mM Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.16 Å
R-free 0.234
|